Skip to main content
Clinical Trials/EUCTR2004-001521-19-CZ
EUCTR2004-001521-19-CZActive, not recruitingNot Applicable

An open clinical trial on teh efficacy of H-AL pollens (Grass mixture I) administered orally and sublingually in patients with indicated allergen immunotherapy (AIT) with Type I allergy mediated by IgE antibodies (pollens allergy), enrolled in the clinical trial according to the protocol MS01092001 -

SEVAPHARMA a.s.0 sites72 target enrollmentStarted: August 20, 2004Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
72

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1.Voluntarily signed informed consent after a complete infromation of teh subject.
  • 2.Subject, who properly finished the clinical trial according to the protocol MS01092001.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • 1.Subject, who did not properly finish the clinical trial according to the protocol MS01092001.
  • 2.Pregnant women and women in lactation.
  • 3.Subject unable of cooperation or irresponsible.
  • 4.Drugs or alcohol addict.
  • 5.Not willing to sign the informed consent.

Investigators

Sponsor
SEVAPHARMA a.s.

Similar Trials

An open clinical trial on teh efficacy of... | Clinical Trial